Reports Q3 revenue ($7.676M), consensus $16.95M.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WVE:
- Wave Life Sciences treatment of Huntington’s disease gets FDA orphan designation
- Wave Life Sciences Pte. Ltd (WVE) Q3 Earnings Cheat Sheet
- Wave Life Sciences price target raised to $22 from $19 at B. Riley
- Largest borrow rate increases among liquid names
- Wave Life Sciences Expands RNA Therapeutic Pipeline